Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary
Gauri R. Varadhachary(The University of Texas MD Anderson Cancer Center), Martin N. Raber(The University of Texas MD Anderson Cancer Center), Renato Lenzi(The University of Texas MD Anderson Cancer Center), Ranit Aharonov(Unknown), Joanna Macinskas(The University of Texas MD Anderson Cancer Center), Siddharth Karanth(The University of Texas Health Science Center at Houston), Yael Spector(Rosetta Genomics (Israel)), Shai Rosenwald(Rosetta Genomics (Israel)), Tina Bocker Edmonston(The University of Texas MD Anderson Cancer Center), James L. Abbruzzese(Duke University), Huamin Wang(The University of Texas MD Anderson Cancer Center), Dalia Cohen(Regulus Therapeutics (United States)), Ayelet Chajut(Rosetta Genomics (Israel)), Heather R. Carlson(The University of Texas MD Anderson Cancer Center)
Cited by 122
Related Papers
MicroRNAs accurately identify cancer tissue origin
|Nature Biotechnology|2008|987
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
|JAMA Oncology|2019|472
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience
|International Journal of Radiation Oncology*Biology*Physics|1999|468
Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma
|Journal of Clinical Oncology|2009|410